Round table: Consensus remains elusive how and when to treat ROP with anti-VEGF vs. laser

There are more questions than answers when pediatric ophthalmologists are faced with treating retinopathy of prematurity. A consensus is yet to be determined on when and whether to use anti-VEGF injections vs. laser, and when and how to treat recurrence.
A study in Ophthalmology identified persistent abnormalities on fluorescein angiography at 4 years after anti-VEGF treatment for ROP. The study sparked debate among members of the OSN Pediatrics/Strabismus Board, who gathered at the American Association for Pediatric Ophthalmology and Strabismus meeting in Washington for a round table

Full Story →